Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-24-037418
Filing Date
2024-03-22
Accepted
2024-03-21 18:20:36
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm248202d5_424b5.htm 424B5 379901
2 GRAPHIC tm248202d5_424b5img001.jpg GRAPHIC 20301
3 GRAPHIC tm248202d5_424b5sp3img001.jpg GRAPHIC 5136
  Complete submission text file 0001104659-24-037418.txt   416371
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-276814 | Film No.: 24772603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)